| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $134.6M | +9.7% |
| Cost of Revenue | $27.1M | +60.8% |
| Gross Profit | $107.6M | +1.6% |
| R&D Expense | $78.5M | +8.3% |
| SG&A Expense | $15.3M | +7.2% |
| Operating Income | -$5.4M | -254.2% |
| Pre-tax Income | -$5.1M | -189.8% |
| Income Tax | $18.1M | +241.6% |
| Net Income | -$23.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.3M | -35.8% |
| Short-term Investments | $408K | -86.0% |
| Accounts Receivable | $31.3M | +13.8% |
| Current Assets | $177.6M | -6.0% |
| Total Assets | $308.4M | -6.2% |
| Current Liabilities | $33.3M | -6.1% |
| Stockholders' Equity | $258.9M | -6.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.9M | -73.2% |
| Capital Expenditures | $3.5M | +59.6% |
| Investing Cash Flow | -$15.1M | +9.5% |
| Financing Cash Flow | -$3.3M | -202.0% |
| Free Cash Flow | $3.4M | -85.5% |
| -5954.3% |
| EPS (Basic) | -$1.00 | -5100.0% |
| EPS (Diluted) | -$1.00 | -5100.0% |